Gina Gambetta

Network details plans for policy work in seven markets, including Australia and Canada.

Corporates, investors and commodity countries split on risks and benefits of proposed postponement.

Off-label use and pricing among concerns amid booming market for drugs made by pharma firms such as Novo Nordisk.

Supporting biodiversity disclosures and aiding capacity building among government plans.

EIB's environmental and biodiversity specialist talks to RI about addressing the climate-nature nexus.

Biodiversity-named funds AUM continues to grow; Iceberg Data Lab launches deforestation tool.

Annual CEC benchmark shows improvement; initiative separately notes public disclosures required for assessment after Canada greenwashing measures saw some firms remove sustainability claims.

The latest ESG movers and shakers: ISS ESG global head of strategy leaves to join Spencer Stuart; Hirt joins Wheb advisory committee.

Major investment firm says membership of key climate initiatives has 'become contested'.

Investors and lawyers look at the implications of changes at the White House and SEC for environmental and social shareholder resolutions.